[go: up one dir, main page]

ES2099747T3 - Aplicacion topica terapeuticamente eficaz de la st1435. - Google Patents

Aplicacion topica terapeuticamente eficaz de la st1435.

Info

Publication number
ES2099747T3
ES2099747T3 ES91912052T ES91912052T ES2099747T3 ES 2099747 T3 ES2099747 T3 ES 2099747T3 ES 91912052 T ES91912052 T ES 91912052T ES 91912052 T ES91912052 T ES 91912052T ES 2099747 T3 ES2099747 T3 ES 2099747T3
Authority
ES
Spain
Prior art keywords
therapeutically effective
topic application
skin
effective topic
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912052T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ES2099747T3 publication Critical patent/ES2099747T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

SE HA DESCUBIERTO QUE CON EL ANALOGO DE LA PROGESTERONA ST 1435, SE PUEDEN OBTENER NIVELES TERAPEUTICAMENTE EFECTIVOS AL APLICARLOS DE FORMA TOPICA EN LA PIEL. EL ST 1435 SE PUEDE ADMINISTRAR TOPICAMENTE BIEN A MODO DE BASE LIQUIDA O SEMISOLIDA TAL COMO UNA CREMA O GEL O BIEN A MODO DE BASE SOLIDA TAL COMO UN DISPOSITIVO TRANSDERMICO TIPO DISCO, PARCHE O BRAZALETE. LA INVENCION SE REFIERE ADEMAS A APLICACIONES TOPICAS ADECUADAS PARA EL SUMINISTRO TRANSDERMICO DE CANTIDADES TERAPEUTICAMENTE EFECTIVAS DE ST 1435.
ES91912052T 1990-06-01 1991-05-24 Aplicacion topica terapeuticamente eficaz de la st1435. Expired - Lifetime ES2099747T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
ES2099747T3 true ES2099747T3 (es) 1997-06-01

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91912052T Expired - Lifetime ES2099747T3 (es) 1990-06-01 1991-05-24 Aplicacion topica terapeuticamente eficaz de la st1435.
ES96201585T Expired - Lifetime ES2180690T3 (es) 1990-06-01 1991-05-24 Preparacion de composiciones que comprenden st1435 para aplicacion topica.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES96201585T Expired - Lifetime ES2180690T3 (es) 1990-06-01 1991-05-24 Preparacion de composiciones que comprenden st1435 para aplicacion topica.

Country Status (10)

Country Link
US (1) US5651973A (es)
EP (3) EP0754456B1 (es)
JP (1) JP2625254B2 (es)
AT (2) ATE151977T1 (es)
CA (1) CA2083404C (es)
DE (2) DE69133077T2 (es)
DK (2) DK0600873T3 (es)
ES (2) ES2099747T3 (es)
GR (1) GR3023312T3 (es)
WO (1) WO1991018570A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151977T1 (de) * 1990-06-01 1997-05-15 Population Council Inc Therapeutisch wirksame, örtliche anwendung von st1435
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003235716A1 (en) * 2002-01-17 2003-07-30 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110220817A1 (en) * 2008-08-12 2011-09-15 Moore John W Method of reducing the distortion of the electromagnetic field
MX363536B (es) 2009-12-17 2019-03-27 Antares Pharma Ipl Ag Gel transdermico de progestina/estradiol.
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
ES2733528T3 (es) 2014-11-25 2019-11-29 Buckman Laboratories Int Inc Acondicionador y limpiador de fieltro

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (es) * 1969-02-13 1970-08-17
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
JP3238389B2 (ja) * 1988-10-27 2001-12-10 シエーリング アクチエンゲゼルシヤフト ゲストデン含有の経皮適用のための薬剤
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
ATE151977T1 (de) * 1990-06-01 1997-05-15 Population Council Inc Therapeutisch wirksame, örtliche anwendung von st1435
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
ATE151977T1 (de) 1997-05-15
EP0754456B1 (en) 2002-07-24
EP0600873A1 (en) 1994-06-15
JP2625254B2 (ja) 1997-07-02
EP0600873B1 (en) 1997-04-23
GR3023312T3 (en) 1997-08-29
EP1093816A2 (en) 2001-04-25
EP0754456A2 (en) 1997-01-22
DE69133077D1 (de) 2002-08-29
DE69133077T2 (de) 2002-11-07
ES2180690T3 (es) 2003-02-16
ATE220912T1 (de) 2002-08-15
WO1991018570A1 (en) 1991-12-12
EP0600873A4 (en) 1993-09-02
CA2083404A1 (en) 1991-12-02
DK0754456T3 (da) 2002-11-11
CA2083404C (en) 2001-02-20
DK0600873T3 (da) 1997-05-20
DE69125855D1 (de) 1997-05-28
JPH07502253A (ja) 1995-03-09
DE69125855T2 (de) 1997-07-31
EP1093816A3 (en) 2003-10-22
US5651973A (en) 1997-07-29
EP0754456A3 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
ES2099747T3 (es) Aplicacion topica terapeuticamente eficaz de la st1435.
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
HUP0104795A2 (hu) CCR5 modulátor hatású azabicikloalkán vegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
SE9702860D0 (sv) New use
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
DE69935720D1 (de) Diamino-propanol-verbindungen zur behandlung von ischaemien
SE8406538D0 (sv) Novel derivatives of purine
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
IE780497L (en) Broparestrol based therapeutic compositions
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
SE8306384L (sv) Farmaceutisk komposition
DK1150981T3 (da) Terapeutisk necleosidforbindelse
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
MX9602996A (es) Benzotiofeno, benzofurano e indolo-tiazepinones, oxazepinones y diazepinones como inhibidores de la adhesion celular y como inhibidores de vih.
JPS53107478A (en) Purification of urokinase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600873

Country of ref document: ES